Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC), an aggressive subtype of pulmonary carcinomas with high mortality, accounts for 85% of all lung cancers. Drug resistance and high recurrence rates impede the chemotherapeutic effect, making it urgent to develop new anti-NSCLC agents. Recently, we have demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jui-Ling, Leu, Wohn-Jenn, Zhong, Nan-Shan, Guh, Jih-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512437/
https://www.ncbi.nlm.nih.gov/pubmed/34641511
http://dx.doi.org/10.3390/molecules26195967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512437/
https://www.ncbi.nlm.nih.gov/pubmed/34641511
http://dx.doi.org/10.3390/molecules26195967

Ejemplares similares